US EditionPublished • loading... • Updated
FDA’s mifepristone decision has baffled both sides
Summary by Las Vegas Sun
1 Articles
1 Articles
FDA’s mifepristone decision has baffled both sides
The Food and Drug Administration’s recent approval of a second generic version of the abortion pill mifepristone has left people on both sides of the reproductive rights fight scrambling to interpret the decision
·Las Vegas, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
